全链条自主创新

Search documents
从“跟跑”到“领跑” 东软医疗光子计数CT正式获批上市
Zheng Quan Ri Bao Wang· 2025-08-29 13:16
Core Viewpoint - Neusoft Medical has successfully developed and launched the NeuViz P10 photon counting CT, marking a significant advancement in medical imaging technology in China, which has been approved by the National Medical Products Administration [1][4]. Group 1: Company Background and Development - Neusoft Medical is a leading medical equipment manufacturer in China, having created the country's first domestically produced CT in 1997, breaking the long-standing foreign monopoly [2]. - The company has made significant technological advancements over the years, progressing from 16-layer to 512-layer CT technologies, culminating in the development of photon counting CT [2][6]. - The journey of Neusoft Medical reflects China's commitment to achieving high-level technological self-reliance and high-quality development in advanced medical equipment [2]. Group 2: Innovation and R&D Process - The development of the photon counting CT began in 2016, with key milestones including the creation of a CZT photon counting detector module in 2018 and the assembly of the first prototype in 2021 [4]. - The successful clinical validation and approval process for the NeuViz P10 was expedited by strategic investment from China General Technology Group, which enhanced R&D capabilities and market competitiveness [5][6]. Group 3: Technological Breakthroughs - The NeuViz P10 utilizes a groundbreaking technology that directly converts X-ray photons into electrical signals, representing a third revolution in CT imaging [7]. - This technology offers advantages such as ultra-high resolution imaging, ultra-low dose scanning, rapid scanning speeds, and multi-energy spectrum imaging [7]. Group 4: Market Strategy and Future Plans - Neusoft Medical aims to leverage the NeuViz P10 as a key tool for international expansion, targeting high-end markets globally [7]. - The company plans to deepen collaboration with China General Technology Group and enhance partnerships with top medical institutions to accelerate the application of photon counting CT in complex disease diagnostics [7].